These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Scleroderma (acrosclerosis). I. Treatment of three cases of the non-calcific variety by Chelation (EDTA). RUKAVINA JG; MENDELSON C; PRICE JM; BROWN RR; JOHNSON SA J Invest Dermatol; 1957 Oct; 29(4):273-88. PubMed ID: 13491891 [No Abstract] [Full Text] [Related]
24. The effect of an intravenous chelating agent, edathamil disodium (Na 2-EDTA), in 3 cases of sarcoidosis. RUKAVINA JG; ORKIN M; LYNCH FW J Invest Dermatol; 1958 Nov; 31(5):259-62. PubMed ID: 13598931 [No Abstract] [Full Text] [Related]
29. [Vascular modifications in progressive diffuse scleroderma; a contribution to the pathology of permeability]. EGER W Med Monatsschr; 1951 Jul; 5(7):474-8. PubMed ID: 14862898 [No Abstract] [Full Text] [Related]
30. Generalized progressive scleroderma or acrosclerosis. CORNBLEET T; SCHORR H; KAGEN M Arch Derm Syphilol; 1948 Mar; 57(3 Pt. 2):446. PubMed ID: 18098650 [No Abstract] [Full Text] [Related]
31. [Cardiac modifications in progressive scleroderma, exacerbated by neosalvarsan therapy]. SCHMITZ R Dermatol Wochenschr; 1951; 124(36):882-9. PubMed ID: 14879557 [No Abstract] [Full Text] [Related]
32. [Progressive scleroderma and the radiological findings]. NAGELE E; PFISTER R Klin Wochenschr; 1954 May; 32(19-20):452-5. PubMed ID: 13164275 [No Abstract] [Full Text] [Related]